<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03033043</url>
  </required_header>
  <id_info>
    <org_study_id>IP-0017-16</org_study_id>
    <nct_id>NCT03033043</nct_id>
  </id_info>
  <brief_title>Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection</brief_title>
  <official_title>A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bolton Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bolton Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is a prospective, multicenter, non-blinded, non-randomized study designed&#xD;
      to assess the RelayPro thoracic endografts in the treatment of acute, complicated type B&#xD;
      aortic dissection. The primary endpoint will measure all-cause mortality at 30 days&#xD;
      post-procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical trial is a prospective, multicenter, non-blinded, non-randomized study designed&#xD;
      to assess the RelayPro thoracic endografts in the treatment of acute, complicated type B&#xD;
      aortic dissection. The primary endpoint will measure all-cause mortality at 30 days&#xD;
      post-procedure.&#xD;
&#xD;
      Subjects will be enrolled on a first come, first serve basis; however, no single&#xD;
      investigational site may enroll more than 20% of the proposed sample size of up to 80&#xD;
      subjects. A subject is considered enrolled when arterial access is gained and an attempt is&#xD;
      made to introduce the RelayPro Thoracic Stent-Graft. Enrollment is expected to begin in&#xD;
      mid-2016 and complete by the end of 2020.&#xD;
&#xD;
      All subjects enrolled, as defined above, will be included in the patient population for the&#xD;
      primary safety analyses. All subjects implanted with the RelayPro Thoracic Stent-Graft will&#xD;
      be included in the patient population for the primary effectiveness analyses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality post-procedure</measure>
    <time_frame>30 days</time_frame>
    <description>All-cause mortality 30 days post-procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success at the time of the index procedure</measure>
    <time_frame>During deployment of the device</time_frame>
    <description>Successful delivery and deployment of the device, including withdrawal of the delivery system;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment success through 1 month</measure>
    <time_frame>1 month, 6 months, 12 months, and annually through 5 years, defined as individual endpoints and as a composite</time_frame>
    <description>Absence of Major adverse Event (MAE)&#xD;
Absence of relevant MAEs:&#xD;
Paraplegia;&#xD;
Paraparesis;&#xD;
New ischemia due to branch vessel compromise;&#xD;
Absence of unintentional rupture of the dissection septum;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dissection Treatment Success</measure>
    <time_frame>1, 6, and 12 month follow-up visits, and annually through 5 years.</time_frame>
    <description>• Dissection treatment success through 1 month, 6 months, 12 months, and annually through 5 years, defined as individual endpoints and as a composite</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aortic Dissection Type B</condition>
  <arm_group>
    <arm_group_label>Experimental: Relay Pro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Relay Pro arm includes subjects who receive the device. The Relay Pro Stent Graft System is administered to treat complicated Type B aortic dissections.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Relay Pro Stent-Graft</intervention_name>
    <description>Endovascular treatment of an aortic dissection</description>
    <arm_group_label>Experimental: Relay Pro</arm_group_label>
    <other_name>Relay Pro Stent Graft System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject must have an acute (symptom onset to diagnosis within 2 weeks)or subacute,&#xD;
             complicated type B aortic dissection (entire dissection is distal to the left&#xD;
             subclavian artery (LSA)), confirmed by Computed Tomography Angiography (CTA) or&#xD;
             Magnetic Resonance Angiogram (MRA), with time from symptom onset to diagnosis ≤ 6&#xD;
             weeks, with at least one of the following:&#xD;
&#xD;
               -  Malperfusion of the viscera, kidneys, spinal cord, or lower extremities, measured&#xD;
                  by clinical or radiographic evidence;&#xD;
&#xD;
               -  Rupture;&#xD;
&#xD;
               -  Intractable pain.&#xD;
&#xD;
          -  Proximal and distal aortic neck with diameter between 19 mm and 42 mm.&#xD;
&#xD;
          -  Subject's anatomy must meet all of the following anatomical criteria:&#xD;
&#xD;
               1. Proximal attachment zone distal to the left common carotid and a distal&#xD;
                  attachment zone proximal to the origin of the celiac artery. (Dissection is&#xD;
                  permitted in the distal attachment zone but is not permitted in the proximal&#xD;
                  attachment zone.)&#xD;
&#xD;
               2. The length of the attachment zones will depend on the intended stent-graft&#xD;
                  diameter and type of graft selected.&#xD;
&#xD;
               3. The proximal attachment zone should be 15 mm for 22 - 28 mm RelayPro grafts with&#xD;
                  bare stent (20 mm for RelayPro grafts with non-bare stent), 20 mm for 30 - 46 mm&#xD;
                  RelayPro grafts with bare stent (25 mm for RelayPro grafts with non-bare stent),&#xD;
                  and proximal to non-dissected segment (healthy zone).&#xD;
&#xD;
               4. The distal attachment zone should be 20 mm for all RelayPro grafts.&#xD;
&#xD;
               5. Coverage of the left subclavian artery is permitted with mandatory&#xD;
                  revascularization if patent left internal mammary artery (LIMA) bypass or left&#xD;
                  upper extremity (LUE) arteriovenous graft or anomalous vertebral artery off the&#xD;
                  aorta. Revascularization must be performed prior to device placement, and may&#xD;
                  occur during implant procedure, provided it is before coverage of the LSA by the&#xD;
                  endograft.&#xD;
&#xD;
          -  Proximal attachment zone containing a straight segment (non-tapered,&#xD;
             non-reverse-tapered, defined by &lt;10% diameter change) with lengths equal to or greater&#xD;
             than the required attachment length for the intended device.&#xD;
&#xD;
          -  Vascular dimensions (e.g., aortic diameters, length from left subclavian to celiac&#xD;
             artery) must be in the range that can be safely treated with the RelayPro Thoracic&#xD;
             Stent-Grafts.&#xD;
&#xD;
          -  Adequate iliac or femoral artery access for introduction of the RelayPro Delivery&#xD;
             System. Alternative methods to gain proper access may be utilized (e.g., iliac&#xD;
             conduit).&#xD;
&#xD;
          -  Subject willing to comply with the follow-up evaluation schedule.&#xD;
&#xD;
          -  Subject (or Legally Authorized Representative, LAR) agrees to sign an Informed Consent&#xD;
             Form prior to treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of traumatic injury or transection of the descending thoracic aorta.&#xD;
&#xD;
          -  Significant stenosis, calcification, thrombus, or tortuosity of intended fixation&#xD;
             sites that would compromise fixation or seal of the device.&#xD;
&#xD;
          -  Planned coverage of left carotid or celiac arteries; or anatomic variants that would&#xD;
             compromise circulation to the carotid, vertebral, or innominate arteries after device&#xD;
             placement, which is not amenable to subclavian revascularization.&#xD;
&#xD;
          -  Prior endovascular or surgical repair in the descending thoracic aorta. The device may&#xD;
             not be placed within any prior endovascular or surgical graft.&#xD;
&#xD;
          -  Concomitant aneurysm/disease of the ascending aorta, aortic arch, or abdominal aorta,&#xD;
             requiring repair. Dissection extension into the abdominal aorta is acceptable.&#xD;
&#xD;
          -  Prior abdominal aortic aneurysm repair (endovascular or surgical) that was performed&#xD;
             less than 6 months prior to the planned stent implant procedure.&#xD;
&#xD;
          -  Major surgical or medical procedure within 30 days prior to the planned procedure, or&#xD;
             is scheduled for a major surgical or medical procedure within 30 days post&#xD;
             implantation. This excludes any planned procedures for the prospective stent-graft&#xD;
             placement.&#xD;
&#xD;
          -  Untreatable allergy or sensitivity to contrast media or device components, including&#xD;
             metal stents.&#xD;
&#xD;
          -  Known or suspected connective tissue disorder.&#xD;
&#xD;
          -  Blood coagulation disorder or bleeding diathesis for which the treatment cannot be&#xD;
             suspended for one week pre- and/or post-repair.&#xD;
&#xD;
          -  Coronary artery disease with unstable angina.&#xD;
&#xD;
          -  Severe congestive heart failure (New York Heart Association functional class IV).&#xD;
&#xD;
          -  Stroke and/or Myocardial Infarction (MI) within 3 months of the planned treatment&#xD;
             date.&#xD;
&#xD;
          -  Pulmonary disease requiring the routine (daily or nightly) need for oxygen therapy&#xD;
             outside the hospital setting.&#xD;
&#xD;
          -  Acute renal failure or chronic renal insufficiency, and not receiving dialysis.&#xD;
&#xD;
          -  Hemodynamically unstable.&#xD;
&#xD;
          -  Active systemic infection and/or mycotic aneurysms.&#xD;
&#xD;
          -  Bowel necrosis.&#xD;
&#xD;
          -  Morbid obesity or other condition that may compromise or prevent the necessary imaging&#xD;
             requirements.&#xD;
&#xD;
          -  ASA risk classification = V (Moribund patient not expected to live 24 hours with or&#xD;
             without operation).&#xD;
&#xD;
          -  Less than two-year life expectancy.&#xD;
&#xD;
          -  Current or planned participation in an investigational drug or device study that has&#xD;
             not completed primary endpoint evaluation.&#xD;
&#xD;
          -  Currently pregnant or planning to become pregnant during the course of the study.&#xD;
&#xD;
          -  Medical, social, or psychological issues that Investigator believes may interfere with&#xD;
             treatment or follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ed Y Woo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MedStar Regional Vascular Program.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie DePetrillo</last_name>
    <phone>2096077566</phone>
    <email>v.depetrillo@terumoaortic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gretchen Wild</last_name>
    <phone>954-579-6393</phone>
    <email>g.wild@terumoaortic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Long Beach Memorial Hospital</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elysse Ballon</last_name>
      <phone>562-933-2334</phone>
      <email>eballon@memorialcare.org</email>
    </contact>
    <investigator>
      <last_name>Ali Khoynezhad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USC Department of Surgery</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pui Yan</last_name>
      <phone>323-442-5693</phone>
      <email>puiyan@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Sukgu Han, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at Los Angeles (UCLA)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Flores</last_name>
      <phone>310-206-1115</phone>
      <email>GabrielaFlores@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>William Quinones-Baldrich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Koyano</last_name>
      <phone>650-724-6921</phone>
      <email>tkoyano3@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Claire Watkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Al-Musawi</last_name>
      <phone>303-724-8583</phone>
      <email>MOHAMMED.AL-MUSAWI@CUANSCHUTZ.EDU</email>
    </contact>
    <investigator>
      <last_name>Brett Reece, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Champagne</last_name>
      <phone>860-972-6049</phone>
      <email>Alison.Champagne@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Mohiuddin Cheema, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelson Molina</last_name>
      <phone>203-785-7031</phone>
      <email>Rodolfo.molina@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Prashanth Vallabhajosyula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medstar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suman Singh</last_name>
      <phone>202-877-8475</phone>
      <email>Suman.Singh@Medstar.net</email>
    </contact>
    <investigator>
      <last_name>Christian Shults, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Harvey</last_name>
      <phone>352-273-5482</phone>
      <email>lmharvey@ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Martin Back, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Dinos</last_name>
      <phone>404-727-8340</phone>
      <email>missy.maton@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Yazan Duwaryi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Warzecha</last_name>
      <email>Anna.Warzecha@nm.org</email>
    </contact>
    <investigator>
      <last_name>Chis S Malaisrie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Fisher</last_name>
      <phone>317-583-7804</phone>
      <email>Jana.Fisher@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Sina Moainie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospital and Clinic</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Pena-Quevedo</last_name>
      <phone>319-353-8736</phone>
      <email>judith-pena-quevedo@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Melhem Sharafuddin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center (UMB)</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Audette</last_name>
      <email>maudette@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Shahab Toursavadkohi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Kasperek</last_name>
      <phone>734-936-9664</phone>
    </contact>
    <investigator>
      <last_name>Shinchi Fukuhara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rutgers Robert Wood Johnson Medical Center</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Med Ctr / Saint Barnabas Med Ctr</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Cook</last_name>
      <phone>973-926-7529</phone>
      <email>debra.cook@rwjbh.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Brener, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Buffalo General Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Stein</last_name>
      <phone>716-888-4859</phone>
      <email>rmstein3@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Maciej Dryjski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Musat</last_name>
      <phone>212-342-4102</phone>
      <email>cm2065@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Virendra Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atrium Health (Sanger Heart &amp; Vascular)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Reeves</last_name>
      <email>Jennifer.Reeves@atriumhealth.org</email>
    </contact>
    <investigator>
      <last_name>John Frederick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Semenac</last_name>
      <phone>216-983-4724</phone>
      <email>Terence.Semenec@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Norman Kumins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lariassa Schaaf</last_name>
      <email>shaafl@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Sean Lyden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Heart Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Dixon</last_name>
      <phone>503-215-6746</phone>
      <email>michelle.dixon@providence.org</email>
    </contact>
    <investigator>
      <last_name>Brant Ullery, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Medical Center / Penn Presbyterian</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Konig</last_name>
      <phone>215-662-8456</phone>
      <email>Marisa.Konig@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Nimesh Desai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lankenau Medical Center</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry McDermott</last_name>
      <phone>484-476-8641</phone>
      <email>mcdermotts@mlhs.org</email>
    </contact>
    <investigator>
      <last_name>Robert Meisner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Central Heart</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patty Eisenbraun</last_name>
      <phone>605-977-5336</phone>
      <email>research@ncheart.com</email>
    </contact>
    <investigator>
      <last_name>J. Michael Bacharach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37664</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terrie Walker</last_name>
      <phone>423-230-5643</phone>
      <email>Terrie.Walker@balladhealth.org</email>
    </contact>
    <investigator>
      <last_name>Chris Metzger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alesia Pruitt</last_name>
      <phone>615-343-5877</phone>
      <email>alesia.l.pruitt@vumc.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Naslund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Surgeons</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnie Punske</last_name>
      <phone>512-651-8406</phone>
      <email>bpunske@ctvstexas.com</email>
    </contact>
    <investigator>
      <last_name>Ryan Turley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Houston- Memorial Hermann Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandro Pizano Umana</last_name>
      <phone>713-486-1593</phone>
      <email>Alejandro.PizanoUmana@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Naveed Saqib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Heart Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Bullivant</last_name>
      <phone>757-388-4024</phone>
      <email>MMBULLIV@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Jean Panneton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Roanoke Memorial Hospital</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brooke Fuhrey</last_name>
      <phone>540-853-0364</phone>
      <email>bfuhrey@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Josh Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Hamar</last_name>
      <phone>206-744-8257</phone>
      <email>wh12@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Benjamin Starnes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of WI, Vascular Surgery</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Weseman</last_name>
      <phone>414-955-1810</phone>
      <email>eweseman@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Rossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 24, 2017</study_first_submitted>
  <study_first_submitted_qc>January 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2017</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic</keyword>
  <keyword>dissection</keyword>
  <keyword>type B</keyword>
  <keyword>thoracic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

